Correlation Between Tryp Therapeutics and XOMA

Can any of the company-specific risk be diversified away by investing in both Tryp Therapeutics and XOMA at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Tryp Therapeutics and XOMA into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Tryp Therapeutics and XOMA Corporation, you can compare the effects of market volatilities on Tryp Therapeutics and XOMA and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Tryp Therapeutics with a short position of XOMA. Check out your portfolio center. Please also check ongoing floating volatility patterns of Tryp Therapeutics and XOMA.

Diversification Opportunities for Tryp Therapeutics and XOMA

-0.2

Correlation Coefficient

Tryp Therapeutics  XOMA

Good diversification

The 3 months correlation between Tryp and XOMA is -0.2. Overlapping area represents the amount of risk that can be diversified away by holding Tryp Therapeutics and XOMA Corp. in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on XOMA and Tryp Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Tryp Therapeutics are associated (or correlated) with XOMA. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of XOMA has no effect on the direction of Tryp Therapeutics i.e., Tryp Therapeutics and XOMA go up and down completely randomly.

Pair Corralation between Tryp Therapeutics and XOMA

If you would invest  2,475  in XOMA Corporation on September 17, 2024 and sell it today you would earn a total of  75.00  from holding XOMA Corporation or generate 3.03% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Insignificant
Accuracy	1.56%
Values	Daily Returns

Tryp Therapeutics  vs.  XOMA Corp.

Tryp Therapeutics

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Tryp Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. Despite nearly stable basic indicators, Tryp Therapeutics is not utilizing all of its potentials. The current stock price disturbance, may contribute to mid-run losses for the stockholders.

XOMA

Risk-Adjusted Performance

10 of 100

OK

Compared to the overall equity markets, risk-adjusted returns on investments in XOMA Corporation are ranked lower than 10 (%) of all global equities and portfolios over the last 90 days. In spite of very healthy basic indicators, XOMA is not utilizing all of its potentials. The latest stock price disarray, may contribute to short-term losses for the investors.

Pair Trading with Tryp Therapeutics and XOMA

The main advantage of trading using opposite Tryp Therapeutics and XOMA positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Tryp Therapeutics position performs unexpectedly, XOMA can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in XOMA will offset losses from the drop in XOMA's long position.

The idea behind Tryp Therapeutics and XOMA Corporation pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Bonds Directory module to find actively traded corporate debentures issued by US companies.